BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 15682321)

  • 1. Recent advances in embryonal tumours of the central nervous system.
    Sarkar C; Deb P; Sharma MC
    Childs Nerv Syst; 2005 Apr; 21(4):272-93. PubMed ID: 15682321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS embryonal tumours: WHO 2016 and beyond.
    Pickles JC; Hawkins C; Pietsch T; Jacques TS
    Neuropathol Appl Neurobiol; 2018 Feb; 44(2):151-162. PubMed ID: 28949028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the diagnosis, molecular genetics, and treatment of pediatric embryonal CNS tumors.
    MacDonald TJ; Rood BR; Santi MR; Vezina G; Bingaman K; Cogen PH; Packer RJ
    Oncologist; 2003; 8(2):174-86. PubMed ID: 12697942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical molecular pathology and histopathology of embryonal tumors.
    Phillips J; Tihan T; Fuller G
    Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonal tumors in the WHO CNS5 classification: A Review.
    Gianno F; Miele E; Antonelli M; Giangaspero F
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of CNS embryonal tumors.
    Momota H; Holland EC
    Brain Tumor Pathol; 2009; 26(2):43-50. PubMed ID: 19856214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
    Shih RY; Koeller KK
    Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of paediatric central nervous system tumours.
    Chiang JC; Ellison DW
    J Pathol; 2017 Jan; 241(2):159-172. PubMed ID: 27701736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up.
    Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H
    Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Outcomes by Treatment Regimen and Histology in Central Nervous System Primary Embryonal Tumors.
    Bhimani AD; Ryoo JS; Reddy AK; Denyer S; McGuire LS; Alonso M; Mehta AI
    World Neurosurg; 2020 Sep; 141():e289-e306. PubMed ID: 32434022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting.
    Cole BL; Pierson CR
    Surg Pathol Clin; 2020 Dec; 13(4):783-800. PubMed ID: 33183733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entities.
    Korshunov A; Jakobiec FA; Eberhart CG; Hovestadt V; Capper D; Jones DT; Sturm D; Stagner AM; Edward DP; Eagle RC; Proia AD; Koch A; Ryzhova M; Ektova A; Schüller U; Zheludkova O; Lichter P; von Deimling A; Pfister SM; Kool M
    Neuropathology; 2015 Dec; 35(6):538-44. PubMed ID: 26183384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in molecular biology of central nervous system embryonal tumors and development of potential molecular targeted therapies].
    Roszkowski M; Grajkowska W
    Neurol Neurochir Pol; 2006; 40(3):212-8. PubMed ID: 16794961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Molecular Classification of CNS Malignancies.
    Spino M; Snuderl M
    Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes.
    Gessi M; Zur Muehlen A; Lauriola L; Gardiman MP; Giangaspero F; Pietsch T
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):406-13. PubMed ID: 21073496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
    Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
    Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive infantile embryonal tumors.
    MacDonald TJ
    J Child Neurol; 2008 Oct; 23(10):1195-204. PubMed ID: 18952586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights.
    Pinheiro JAF; de Almeida JCM; Lopes JMPB
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):79-89. PubMed ID: 32925406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonal tumors of the central nervous system.
    Pagès M; Masliah-Planchon J; Bourdeaut F
    Curr Opin Oncol; 2020 Nov; 32(6):623-630. PubMed ID: 32890024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric embryonic brain tumours. biological and clinical relevance of molecular genetic abnormalities.
    Gilbertson R
    Eur J Cancer; 2002 Mar; 38(5):675-85. PubMed ID: 11916550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.